- XRP $5 call sparks debate as analysts, investors question bullish 12 month target
- Cineplex Q2 2026 revenue rises 9.8% as attendance increases, company says
- Marfrig buys back 10.63 million shares for R$ 160.72 million
- US Treasuries hold steady ahead of CPI; oil prices approach $90, intensifying tension; 30-year yield hits near 20-year high
- Cardinal Infrastructure Group Inc. Reports Second Quarter 2026 Results And Updates 2026 Outlook, Announces Acquisition Of Allied Paving >CDNL
- Jiutian Chemical says arbitration claim is withdrawn, tribunal orders claimant to pay RMB 70,000 costs
- Basler supervisory board member Dr. Holger Singpiel buys shares for EUR 4,630
- Cardinal Health Sees FY Global Medical Products and Distribution Segment Rev Grwoth of 2% to 4% >CAH
- Cardinal Health Sees FY Pharmaceutical and Specialty Solutions Segment Rev Growth of 3% to 5% >CAH
- Cardinal Health 4Q Pharmaceutical and Specialty Solutions Segment Rev Increased 6% to $58.8B >CAH
- Cardinal Health 4Q Global Medical Products and Distribution Segment Rev Decreased 2% to $3.1B >CAH
- ABCELLERA BIOLOGICS INC. : BMO RAISES TARGET PRICE TO $15 FROM $7
- Cardinal Health Sees FY Adj EPS $12.40-Adj EPS $12.60 >CAH
- Uniper warns that gas prices are unlikely to drop; if the Strait of Hormuz does not reopen, prices of 50 to 60 euros will become the norm
- SEA's Q2 revenue was $7.788 billion, up 48.1% year-on-year; diluted earnings per share were $0.70, an increase of 7.7% year-on-year.
- BRIEF-Cardinal Health Q4 Adjusted EPS USD 2.91 Vs. IBES Estimate USD 2.42
- HIMS & HERS HEALTH, INC. <HIMS.N>: NEEDHAM RAISES TARGET PRICE TO $42 FROM $35
- Yimutian announces annual shareholder meeting
- IHS Holding announces availability of Q2 2026 earnings release
- Jacobs wins CUWCD engineering role on USD 750 million Utah Strawberry High Line water pipeline project
- Blue Moon Metals acquires 33 US tungsten, antimony projects for US$5 million and 2,800,000 shares
- Twenty One Capital targets Berkshire-style buildout of operating businesses around Bitcoin balance sheet
- Cardinal Health 4Q Adj EPS $2.91 >CAH
- Cardinal Health 4Q EPS $1.70 >CAH
- Major Canadian Economic Indicators Expected This Week
- TARGET CORP <TGT.N>: BMO RAISES TARGET PRICE TO $150 FROM $130
- Lithium Argentina Q2 2026 profit falls as company cites US$ 38 million deferred tax charge at Cauchari-Olaroz JV
- H&R REIT releases presentation for Aug. 11, 2026 joint conference call on GO REIT deal
- NUTRIEN LTD <NTR.N>: BARCLAYS CUTS TARGET PRICE TO $78 FROM $81
- IHS Holding amends USD 200 million term loan, resets margin schedule
- Tritech 1Q FY27 net loss widens 27.1% to S$ 1.01 million; revenue falls 4.3% to S$ 4.56 million
- Brent crude and US crude oil gave back some of their gains as a spokesperson for the Qatari government stated that negotiations between Oman and Iran have entered an advanced stage.
- Commerzbank: Raises European natural gas price forecast, now expects €50/MWh by end of 2026, previously projected at €45/MWh
- Foreign media: Software stocks and bitcoin show rare divergence in performance
- Cardinal Health declares quarterly dividend of $0.52 per share
- Nutriplant returns to profit with 6M FY26 net income of R$ 538,000; net revenue falls 34.1% to R$ 74.14 million
- Vireo Q2 FY26 adjusted EBITDA climbs 212% to US $41.5 million; GAAP revenue rises 335.1% to US $209.3 million
- P&P Immobilienverwaltung, closely associated with Athos board member Manfred Pammer, buys 350 Athos shares (ISIN AT0000616701) at 43.00 per share
- NATIONAL ENERGY SERVICES REUNITED CORP. <NESR.O>: BARCLAYS RAISES TARGET PRICE TO $45 FROM $35
- Cardinal Health signs $4 billion revolving credit facility, replacing existing lines
- Goodland to use completed 1377 Serangoon Road commercial building as new HQ, investment property
- RH <RH.N>: WELLS FARGO RAISES TARGET PRICE TO $225 FROM $175
- HIMS & HERS HEALTH, INC. <HIMS.N>: CITIGROUP CUTS TARGET PRICE TO $33 FROM $35
- Singapore Land dissolves Peak Venture joint venture after voluntary liquidation
- IHS Towers Q2 FY26 turns to IFRS net loss of USD 7.5 million; revenue from continuing operations rises 10.4% to USD 428.6 million
- Lithium Argentina 2Q EPS C$0.01 >LAR.T
- OPTIMUM COMMUNICATIONS, INC. <OPTU.N>: WELLS FARGO CUTS TARGET PRICE TO $0.75 FROM $1
- SYNOPSYS, INC. <SNPS.O>: WELLS FARGO CUTS TARGET PRICE TO $450 FROM $535
- THE E.W. SCRIPPS CO. <SSP.O>: WELLS FARGO CUTS TARGET PRICE TO $3.8 FROM $4.7
- THE PENNANT GROUP, INC. : WELLS FARGO RAISES TARGET PRICE TO $46 FROM $45
- NIQ GLOBAL INTELLIGENCE PLC <NIQ.N>: WELLS FARGO RAISES TARGET PRICE TO $16.5 FROM $13
- METAGENOMI THERAPEUTICS, INC. <MGX.O>: WELLS FARGO CUTS TARGET PRICE TO $7 FROM $9
- AXSOME THERAPEUTICS, INC. : WELLS FARGO RAISES TARGET PRICE TO $256 FROM $255
- AGILON HEALTH, INC. : WELLS FARGO RAISES TARGET PRICE TO $146 FROM $141
- MCKESSON CORPORATION <MCK.N>: WELLS FARGO RAISES TARGET PRICE TO $933 FROM $812
- MEDLINE, INC. <MDLN.O>: WELLS FARGO CUTS TARGET PRICE TO $34 FROM $45
- CONCENTRA GROUP HOLDINGS PARENT, INC. <CON.N>: WELLS FARGO RAISES TARGET PRICE TO $40 FROM $28
- WILLIAMS-SONOMA, INC. <WSM.N>: WELLS FARGO RAISES TARGET PRICE TO $240 FROM $190
- BRIDGEBIO PHARMA, INC. <BBIO.O>: WELLS FARGO RAISES TARGET PRICE TO $102 FROM $98
- BEST BUY COMPANY, INC. <BBY.N>: WELLS FARGO RAISES TARGET PRICE TO $85 FROM $65
- THE HOME DEPOT, INC. <HD.N>: WELLS FARGO RAISES TARGET PRICE TO $400 FROM $360
- LOWE'S COMPANIES, INC. <LOW.N>: WELLS FARGO CUTS TARGET PRICE TO $245 FROM $255
- CENCORA INC. <COR.N>: WELLS FARGO RAISES TARGET PRICE TO $395 FROM $331
- Singapore Land FY26 H1 PATMI rises 90% to S$ 211.75 million; revenue increases 2% to S$ 376.77 million
- PAR PACIFIC HOLDINGS INC : MIZUHO RAISES TARGET PRICE TO $85 FROM $80
- Lithium Argentina swings to Q2 FY26 net income of $1.3 million; income rises to $2.3 million
- MARATHON PETROLEUM CORPORATION <MPC.N>: MIZUHO RAISES TARGET PRICE TO $304 FROM $284
- DELEK US HOLDINGS INC <DK.N>: MIZUHO RAISES TARGET PRICE TO $66 FROM $60
- Hyperscale Data: Range of Alternatives Include Potential Sale or Lease of Portion or All of Data Center for Cash, Strategic Investment or Joint Venture or Continued Ownership and Development of the Assets >GPUS
- Hyperscale Data Has Begun Discussions With Major Investment Banking Firm >GPUS
- Hyperscale Data: Strategic Alternatives Include Sale for Cash and Strategic Partnerships, Among Other Options >GPUS
- Immunic 2Q Research and Development Expenses $25.9M >IMUX
- ABERCROMBIE & FITCH CO. : BARCLAYS RAISES TARGET PRICE TO $114 FROM $78
- THE GAP, INC. <GAP.N>: BARCLAYS CUTS TARGET PRICE TO $20 FROM $26
- STANDARD NUCLEAR, INC. <STDN.N>: BARCLAYS INITIATES COVERAGE WITH OVERWEIGHT RATING AND TARGET PRICE $17
- ABERCROMBIE & FITCH CO. : BARCLAYS RAISES TARGET PRICE TO $114 FROM $78
- THE GAP, INC. <GAP.N>: BARCLAYS CUTS TARGET PRICE TO $20 FROM $26
- UNDER ARMOUR, INC. <UAA.N>: BARCLAYS CUTS TO UNDERWEIGHT FROM EQUAL-WEIGHT
- ALTRIA GROUP INC. <MO.N>: BARCLAYS CUTS TARGET PRICE TO $58 FROM $64
- ASPEN AEROGELS INC. : BARCLAYS RAISES TARGET PRICE TO $5 FROM $4
- BKV CORPORATION <BKV.N>: BARCLAYS RAISES TARGET PRICE TO $36 FROM $35
- BROOKDALE SENIOR LIVING INC. <BKD.N>: BARCLAYS CUTS TARGET PRICE TO $17 FROM $18
- ResMed CEO Michael J. Farrell reports disposal of 4,991 common shares worth $1,026,594.05
- BRIEF-Aramark Q3 EPS USD 0.36
- BRIEF-Cineplex Q2 EPS CAD 0.12
- BRIEF-Pet Valu Q2 Net Income CAD 24.933 Million
- Immunic Q2 net loss widens to $34.1 million; operating expenses rise to $35.3 million
- Westwater Resources schedules webcast on second-quarter 2026 results
- Cineplex Q2 FY26 net income turns to profit at CAD 7.8 million; revenue rises 9.8% to CAD 383.7 million
- XCF Global sells renewable diesel from Reno refinery to Tartan Oil
- Parsons wins $40 million US Army electronic warfare contract
- Babcock & Wilcox signs Siemens Energy deal to start work on 20 steam turbines for data centers
- Cineplex 2Q Rev C$383.7M >CGX.T
- Cineplex 2Q EPS C$0.12 >CGX.T
- Pet Valu Holdings 2Q EPS 37c >PET.T
- Venture Global: Xpect to Export 149-154 Cargos From Calcasieu Pass and 351-364 Cargos From Plaquemines in 2026 >VG
- Venture Global Now Sees 2026 Consolidated Adj Ebitda $8.7B-$9.1B, Up From Prior View $8.2B-$8.5B >VG
- Venture Global: Exported 127 Cargos and Sold 466.4 TBtu of Liquefied Natural Gas in 2Q >VG
- Venture Global 2Q Consolidated Adj Ebitda $2.5B >VG
- Venture Global 2Q EPS 51c >VG
